Patent ID: 11957719
Assignee: SCHEPENS EYE RESEARCH INSTITUTE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C  G

Claim 3:
4. An expanded population of human retinal progenitor cells having been expanded in from about 10 ng/ml to about 20 ng/ml epidermal growth factor and from about 10 ng/ml to about 20 ng/ml basic fibroblast growth factor in low oxygen conditions consisting of about 3% oxygen for at least 6 hours and wherein at least 90% of the population of the cells express the following identifiable markers SOX2, Recoverin, CD73, Beta3tubulin, NF200, Nestin, and PTK7 but not expressing CD15 and CD133, and wherein the population is expanded for at least 8 passages.